Featured Article

Cancer is a heartbreaking diagnosis for any person to hear. It is one of the most serious and challenging conditions one can face. For those who are diagnosed with metastatic non-small cell lung cancer (NSCLC), it can be a daunting prospect. Fortunately, the treatment for metastatic NSCLC has been advancing over the years, leading to a number of positive benefits that can be gained.

Metastatic NSCLC refers to where cancer cells from the lungs have spread to other organs in the body. Whilst the condition cannot always be cured, there are a number of treatments that can be used to reduce the size of the tumours and keep them under control. The main treatments used are chemotherapy, targeted therapy, radiotherapy, surgery and immunotherapy.

Each of these treatments has a number of positive benefits for those diagnosed with metastatic NSCLC. For example, chemotherapy was once the only treatment available and was often successful in providing relief from the symptoms of the condition. However, it can come with a number of negative side effects, including nausea and fatigue.

Targeted therapy, which uses drugs that block cancer cells from growing, works to both reduce the size of the tumours and also reduce the risk of recurrence. It also has fewer side effects than chemotherapy and can therefore be more convenient for the patient.

Radiotherapy is another form of treatment that is used to shrink tumours and it can be used in conjunction with surgery and chemotherapy. Radiotherapy can be extremely effective for reducing the size of the cancer cells, while at the same time offering less risk of serious side effects.

Surgery is often the last resort for treating metastatic NSCLC but can be extremely beneficial in reducing the size of the tumours. However, it is important to realise that the conditions surrounding metastatic NSCLC means that it is not always possible to completely remove the cancerous cells.

Finally, immunotherapy works by harnessing the body’s own immune system to fight cancer cells. It is becoming an increasingly popular form of treatment for metastatic NSCLC and studies have found promising results, with some patients showing a significant reduction in their tumours.

Overall, whilst metastatic NSCLC remains a difficult condition to treat, the recent advances in treatment have brought a number of positive benefits. From reducing the size of tumours to offering more convenient treatments such as targeted therapy, the benefits of treatments for metastatic NSCLC are clear. By working with their doctor, those diagnosed with the condition can take great strides in managing the condition and improving their quality of life.